journal article·2023-01-17Open access

Novel Injectable Fluorescent Polymeric Nanocarriers for Intervertebral Disc Application

Michael R. Arul, Changli Zhang, Ibtihal Alahmadi, Isaac L. Moss, Yeshavanth Kumar Banasavadi-Siddegowda, Sama Abdulmalik, Svenja Illien-Junger, Sangamesh G. Kumbar

Abstract

Damage to intervertebral discs (IVD) can lead to chronic pain and disability, and no current treatments can fully restore their function. Some non-surgical treatments have shown promise; however, these approaches are generally limited by burst release and poor localization of diverse molecules. In this proof-of-concept study, we developed a nanoparticle (NP) delivery system to efficiently deliver high- and low-solubility drug molecules. Nanoparticles of cellulose acetate and polycaprolactone-polyethylene glycol conjugated with 1-oxo-1H-pyrido [2,1-b][1,3]benzoxazole-3-carboxylic acid (PBC), a novel fluorescent dye, were prepared by the oil-in-water emulsion. Two drugs, a water insoluble indomethacin (IND) and a water soluble 4-aminopyridine (4-AP), were used to study their release patterns. Electron microscopy confirmed the spherical nature and rough surface of nanoparticles. The particle size analysis revealed a hydrodynamic radius ranging ~150–162 nm based on dynamic light scattering. Zeta potential increased with PBC conjugation implying their enhanced stability. IND encapsulation efficiency was almost 3-fold higher than 4-AP, with release lasting up to 4 days, signifying enhanced solubility, while the release of 4-AP continued for up to 7 days. Nanoparticles and their drug formulations did not show any apparent cytotoxicity and were taken up by human IVD nucleus pulposus cells. When injected into coccygeal mouse IVDs in vivo, the nanoparticles remained within the nucleus pulposus cells and the injection site of the nucleus pulposus and annulus fibrosus of the IVD. These fluorescent nano-formulations may serve as a platform technology to deliver therapeutic agents to IVDs and other tissues that require localized drug injections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spine and Intervertebral Disc Pathology · Anesthesia and Pain Management · Musculoskeletal pain and rehabilitation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Surgery, University of Connecticut Health, Farmington, CT 06030, USA

Department of Orthopedic Surgery, Emory University, Atlanta, GA 30308, USA

Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, USA

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA

Department of Materials Science and Engineering, University of Connecticut, Storrs, CT 06269, USA

Funding

National Institutes of Biomedical Imaging and Bioengineering · U.S. Army Medical Research Acquisition Activity (USAMRAA) · National Institute of Arthritis and Musculoskeletal and Skin Diseases

References (81)

Show source-provided references
1. “Old Drugs, New Tricks”—Local controlled drug release systems for treatment of degenerative joint disease10.1016/j.addr.2020.10.012 ↗
2. Inflammation in intervertebral disc degeneration and regeneration10.1098/rsif.2014.1191 ↗
3. Point of View: Avoiding Opioids in Patients With Work-related Lumbar Disc Herniation10.1097/BRS.0000000000002434 ↗
4. Preoperative Opioid Use and Clinical Outcomes in Spine Surgery: A Systematic Review10.1093/neuros/nyaa050 ↗
5. Painful intervertebral disc degeneration and inflammation: From laboratory evidence to clinical interventions10.1038/s41413-020-00125-x ↗
6. Pathomechanism of intervertebral disc degeneration10.1002/jsp2.1076 ↗
7. What is intervertebral disc degeneration, and what causes it?10.1097/01.brs.0000231761.73859.2c ↗
8. The clinical correlations between diabetes, cigarette smoking and obesity on intervertebral degenerative disc disease of the lumbar spine10.4184/asj.2017.11.3.337 ↗
9. Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: A review10.1038/s41434-018-0004-0 ↗
10. Mesenchymal stem cells injection in degenerated intervertebral disc: Cell leakage may induce osteophyte formation10.1002/term.433 ↗
11. Adeno-associated virus-mediated BMP-7 and SOX9 in vitro co-transfection of human degenerative intervertebral disc cells10.4238/2015.April.22.1 ↗
12. Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells?10.1002/jsp2.1043 ↗
13. Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells10.1097/BRS.0b013e3180593238 ↗
14. Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling10.3389/fcell.2021.687024 ↗
15. Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential treatment for degenerative disc disease10.1016/j.joca.2017.02.688 ↗
16. Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges10.1208/s12248-015-9814-9 ↗
17. Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs10.1016/j.fjps.2018.04.001 ↗
18. Improving in vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems10.1155/2017/7351976 ↗
19. Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents10.1016/j.jconrel.2020.08.041 ↗
20. An overview of clinical and commercial impact of drug delivery systems10.1016/j.jconrel.2014.03.053 ↗
21. Larrañeta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R., and Donnelly, R.F. (2018). Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications. J. Funct. Biomater., 9.10.3390/jfb9010013 ↗
22. Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases10.3389/fbioe.2020.00251 ↗
23. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release10.1021/acs.chemrev.5b00346 ↗
24. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles10.1038/s41392-019-0068-3 ↗
25. Polymeric nanoparticles: Potent vectors for vaccine delivery targeting cancer and infectious diseases10.4161/hv.26796 ↗
26. Nano based drug delivery systems: Recent developments and future prospects10.1186/s12951-018-0392-8 ↗
27. Biodegradable Conducting Polymeric Implants for Tissue Regeneration, Imaging and Drug Delivery Applications
28. In vivo release of water-soluble drugs from stabilized water-in-oil-in-water (W/O/W) type multiple emulsions following intravenous administrations using rats10.1248/bpb.16.268 ↗
29. Synthesis and characterization of polyacrylamide-grafted chitosan hydrogel microspheres for the controlled release of indomethacin10.1002/app.11552 ↗
30. Effect of Polyethylene Glycol on Properties and Drug Encapsulation–Release Performance of Biodegradable/Cytocompatible Agarose–Polyethylene Glycol–Polycaprolactone Amphiphilic Co-Network Gels10.1021/acsami.5b10675 ↗
31. Taste masking of azithromycin by resin complex and sustained release through interpenetrating polymer network with functionalized biopolymers10.1080/03639045.2016.1224894 ↗
32. Biodegradable Polymeric Injectable Implants for Long-Term Delivery of Contraceptive Drugs10.1002/app.46068 ↗
33. Oil-in-water nanoemulsions are suitable for carrying hydrophobic compounds: Indomethacin as a model of anti-inflammatory drug10.1016/j.ijpharm.2016.11.016 ↗
34. Biopolymer-nanotube nerve guidance conduit drug delivery for peripheral nerve regeneration: In vivo structural and functional assessment10.1016/j.bioactmat.2021.02.016 ↗
35. Aligned microchannel polymer-nanotube composites for peripheral nerve regeneration: Small molecule drug delivery10.1016/j.jconrel.2019.01.013 ↗
36. Functional Polysaccharide Composite Nanoparticles from Cellulose Acetate and Potential Applications10.1002/adfm.201102350 ↗
37. MPEG–PCL copolymeric nanoparticles in drug delivery systems10.1080/2331205X.2016.1142411 ↗
38. Taste masking of ofloxacin and formation of interpenetrating polymer network beads for sustained release10.1016/j.jpha.2016.11.001 ↗
39. Nutrition of the intervertebral disk: An in vivo study of solute transport10.1097/00003086-197711000-00012 ↗
40. Recent advances in biological therapies for disc degeneration: Tissue engineering of the annulus fibrosus, nucleus pulposus and whole intervertebral discs10.1016/j.copbio.2013.04.012 ↗
41. Cellular uptake of nanoparticles: Journey inside the cell10.1039/C6CS00636A ↗
42. Use of Nanoparticles in Tissue Engineering and Regenerative Medicine10.3389/fbioe.2019.00113 ↗
43. Advances of Naturally Derived and Synthetic Hydrogels for Intervertebral Disk Regeneration10.3389/fbioe.2020.00745 ↗
44. Applications of Cellulose-based Materials in Sustained Drug Delivery Systems10.2174/0929867324666170705143308 ↗
45. Enzymatic Polymerization of PCL-PEG Co-polymers for Biomedical Applications10.3389/fmolb.2019.00109 ↗
46. Wasilewska, K., and Winnicka, K. (2019). Ethylcellulose-A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development. Materials, 12.10.3390/ma12203386 ↗
47. Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors10.3389/fphar.2021.601626 ↗
48. An overview of injectable polymeric hydrogels for tissue engineering10.1016/j.eurpolymj.2015.05.014 ↗
49. Characterization of biomaterials intended for use in the nucleus pulposus of degenerated intervertebral discs10.1016/j.actbio.2020.08.001 ↗
50. Lee, C.K., Heo, D.H., Chung, H., Roh, E.J., Darai, A., Kyung, J.W., Choi, H., Kwon, S.Y., Bhujel, B., and Han, I. (2021). Advances in Tissue Engineering for Disc Repair. Appl. Sci., 11.10.3390/app11041919 ↗
51. An insight to osmotic drug delivery10.2174/156720112800389106 ↗
52. Cunha, C., Teixeira, G., Ribeiro-Machado, C., Pereira, L.C., Ferreira, J.R., Molinos, M., Santos, G.S., Barbosa, M.A., and Goncalves, R. (2020). Modulation of the In Vivo Inflammatory Response by Pro- Versus Anti-Inflammatory Intervertebral Disc Treatments. Int. J. Mol. Sci., 21.10.3390/ijms21051730 ↗
53. An overview of nanoparticles commonly used in fluorescent bioimaging10.1039/C4CS00392F ↗
54. Circumventing photodamage in live-cell microscopy10.1016/B978-0-12-407761-4.00023-3 ↗
55. Quantum dots in cell imaging and their safety issues10.1039/D1TB00729G ↗
56. A Review of Indocyanine Green Fluorescent Imaging in Surgery10.1155/2012/940585 ↗
57. Braeken, Y., Cheruku, S., Ethirajan, A., and Maes, W. (2017). Conjugated Polymer Nanoparticles for Bioimaging. Materials, 10.10.3390/ma10121420 ↗
58. Synthesis and characterization of citrate-based fluorescent small molecules and biodegradable polymers10.1016/j.actbio.2017.01.019 ↗
59. Wide Range of Functionalized Poly(N-alkyl acrylamide)-Based Amphiphilic Polymer Conetworks via Active Ester Precursors10.1021/acs.macromol.8b00841 ↗
60. Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging10.1002/smll.201503396 ↗
61. Conjugated polymer nanoparticles10.1039/b9nr00374f ↗
62. Preparation and evaluation of PCL–PEG–PCL polymeric nanoparticles for doxorubicin delivery against breast cancer10.1039/C6RA04687H ↗
63. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method10.1016/j.ijpharm.2005.04.029 ↗
64. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
65. Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery10.1007/s11095-012-0958-3 ↗
66. Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity10.1016/j.jconrel.2019.02.030 ↗
67. Song, W., Su, X., Gregory, D.A., Li, W., Cai, Z., and Zhao, X. (2018). Magnetic Alginate/Chitosan Nanoparticles for Targeted Delivery of Curcumin into Human Breast Cancer Cells. Nanomaterials, 8.10.20944/preprints201809.0558.v1 ↗
68. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles10.1038/s41598-018-23317-2 ↗
69. Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells10.1111/cpr.12192 ↗
70. Arbeiter, D., Reske, T., Teske, M., Bajer, D., Senz, V., Schmitz, K.-P., Grabow, N., and Oschatz, S. (2021). Influence of Drug Incorporation on the Physico-Chemical Properties of Poly(l-Lactide) Implant Coating Matrices-A Systematic Study. Polymers, 13.10.3390/polym13020292 ↗
71. Nanonization techniques to overcome poor water-solubility with drugs10.1080/17460441.2020.1750591 ↗
72. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: Newer formulation techniques, current marketed scenario and patents10.1080/10717544.2020.1846638 ↗
73. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems10.1517/17425241003602259 ↗
74. Vergadou, N., and Theodorou, D.N. (2019). Molecular Modeling Investigations of Sorption and Diffusion of Small Molecules in Glassy Polymers. Membranes, 9.10.3390/membranes9080098 ↗
75. Theoretical and experimental studies on theophylline release from hydrophilic alginate nanoparticles10.1186/s43094-019-0002-0 ↗
76. Nanoparticles Based on Hydrophobic Polysaccharide Derivatives—Formation Principles, Characterization Techniques, and Biomedical Applications10.1002/mabi.201900415 ↗
77. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles10.1186/s11671-018-2728-6 ↗
78. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells10.1016/j.biomaterials.2005.12.022 ↗
79. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells10.1088/0957-4484/22/10/105708 ↗
80. Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization10.3389/fmolb.2020.587012 ↗
81. Understanding the interactions of poly(methyl methacrylate) and poly(vinyl chloride) nanoparticles with BHK-21 cell line10.1038/s41598-020-80708-0 ↗